autoimmune diagonstics

Global Autoimmune diagonstics Market
The Global Autoimmune diagnostics Market was worth $13.07 billion in 2016 and
estimated to reach $15.6 billion by the end of 2021 with a growing potential of 3.6%.
Autoimmune disease is a disorder where the patient’s immune system attacks own body
tissues that led to the damage of body organs. Nearly 80 types of autoimmune diseases
are known so far.
The Global Auto immune diagnostics market is expected to show tremendous growth
due to Mergers & acquisitions between research institutes and the companies.
Increasing advancements in new technologies and services are expected to increase
the Point of care tests which will change the dynamics of the market over the forecast
period. The most common autoimmune diseases include Graves’ disease, rheumatoid
arthritis, Hashimoto’s thyroiditis, type1 diabetes, multiple sclerosis and systemic lupus
erythematosus.
Recent discoveries in auto immune disease diagnostic techniques, upgraded laboratory
techniques, increasing public awareness for autoimmune disorders and automation are
the major factors driving the growth of the market. The key restraints that inhibiting the
growth of the auto immune diagnostics market are Competitive pricing among the major
manufacturers, unavailability of skilled manpower and growing demand for innovative
technological products.
The Global Auto immune diagnostics Market is broadly categorized based on Test type
into Autoantibody Tests, Antinuclear Antibody Tests, Complete Blood Count (CBC), C -
reactive protein (CRP), Comprehensive Metabolic panel, Urinalysis, Erythrocyte
Sedimentation Rate (ESR) and others.
Based on Disease type the market is categorized into Localized auto immune disease
diagnostics and systemic auto immune disease diagnostics. Local auto immune disease
diagnostics is further classified into Graves disease, Hashimoto's Thyroiditis, Type 1
diabetes, Multiple Sclerosis, Psoriasis and Others. Systemic auto immune disease
diagnostics is categorized into Rheumatoid Arthritis (RA), Systemic Lupus
Erythematosus (SLE), Ankylosing Spondylitis. The occurrence of rheumatoid arthritis is
the highest since it can occur at any age. Rheumatoid arthritis has therefore accounts
for the largest segment in the autoimmune disease diagnostics market, based on
disease type.
Based on End users into Hospitals, Research centers, and diagnostic laboratories and
on the basis of geography, the Auto immune Diagnostics market is analysed under
various regions namely North America, Europe, Asia-Pacific, Latin America, and Middle
East and Africa. North America dominates the global autoimmune diagnostics market
with highest share followed by Europe, Asia - Pacific. Asia-Pacific market is expected to
account highest growth during the forecast period.
Some of the major companies dominating the global Auto immune disease market by
their products and services include Bio-Rad, Siemens Healthcare, Abbott Laboratories,
Crescendo Bioscience, Roche Diagnostics SQI Diagnostics, AESKU Diagnostics,
INOVA Diagnostics Inc., BioMerieux SA, Beckman Coulter Inc., Hemagen Diagnostics,
Quest Diagnostics, Eli lilly, Glaxosmithkline Plc.
TABLE OF CONTENTS
1. Introduction
1.1 Market Definition
+1 888-702-9626 | www.marketdataforecast.com | contact@marketdataforecast.com